NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender Women

NCT07361926

Not Yet RecruitingNA

Sponsor: University of Washington

Conditions: Sexually Transmitted Infections (Not HIV or Hepatitis), HIV Infections

Interventions: doxy-PEP, Serial STI testing, HIV PEP/PrEP

This proposed 3-arm randomized study will compare different pharmacy based approaches that include HIV prevention medication (PrEP and PEP), routine STI testing, and preventive antibiotic (doxycycline) for STIs. The study will assess how well these services can be implemented, how acceptable they are to young women, and whether they are cost-effective.

Eligibility overview

Sex: FEMALE

Age: 15 Years to 24 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Cis-gender female
* Seeking contraception (emergency contraception, oral contraceptive pills, injectables, implants, and condoms) from the retail pharmacy site
* Age ≥ 15 and \<25 years old
* Willingness to receive PrEP screening per national guidelines including HIV testing
* Not currently taking PrEP
* Planning to reside in the area for the next 12 months
* Able and willing to provide informed consent for participation

Exclusion Criteria:

* Current participation in other ongoing studies.
* Medical contraindications to PrEP or doxycycline use (e.g., severe allergy to doxycycline, serious hepatic or renal disease).
* Any other condition that, in the investigator's judgment, would make participation unsafe or interfere with study procedures.